Alejandro Ocampo Profile Banner
Alejandro Ocampo Profile
Alejandro Ocampo

@aocampox

Followers
719
Following
179
Media
4
Statuses
163

Scientist on a mission to make dogs live longer and healthier lives. Assistant Professor at @unil Co-Founder and CEO at @epiterna_

Switzerland
Joined July 2023
Don't wanna be here? Send us removal request.
Explore trending content on Musk Viewer
@aocampox
Alejandro Ocampo
7 months
Great paper demonstrating the extension of lifespan in wild-type mice by in vivo reprogramming! Although this is a great first step, I believe we are all waiting for a much stronger effect once we overcome the technical barriers. Let’s keep working together to get there!
@CellRepJrnl
Cellular Reprogramming
7 months
Our new article reveals that gene therapy-mediated partial reprogramming extends lifespan and reverses age-related changes in aged mice, showcasing lifespan extension in wild-type animals through in vivo reprogramming. @eskamoah @cc_biology_ @rejuvenatebio
Tweet media one
12
59
209
1
13
59
@aocampox
Alejandro Ocampo
8 months
2023 has been without any doubt the most difficult year of my life, both personally and professionally. Lots of pain and suffer, but most important, lots of lessons and learnings that will allow me to continue growing. Tomorrow will be “Day One” and the mission continues!🚀💯🐶❤️
4
1
47
@aocampox
Alejandro Ocampo
9 months
Every time I pass by an old dog and see the pain, innocence, and confusion in their eyes, I know that I have found a purpose in life. Difficult to understand for people who have never had dogs, but easy if you have ever shared your life with one. 🐶❤️
3
3
46
@aocampox
Alejandro Ocampo
1 year
I am excited to announce @epiterna_ , a spin-off from my laboratory @OcampoLab at @unil . Longevity research is coming of age. Using a unique high-throughput drug screening platform, our mission is to create more time that matters for people and their pets.
3
10
46
@aocampox
Alejandro Ocampo
8 months
Several weeks after the news, I believe we still not fully understand the importance of what @loyal has achieved with the FDA. This is going to have immense consequences for the field as we move forward. Congratulations to @celinehalioua and the team at @loyal and thank you! 🐶🚀
2
3
35
@aocampox
Alejandro Ocampo
9 months
I would really like to see more clinical trials for extension of healthy lifespan. We know these trials will be long, expensive, and difficult (not imposible) from a regulatory point of view. Still, someone needs to start running them!
3
4
33
@aocampox
Alejandro Ocampo
6 months
So much to discover about the fundamental principles of in vivo reprogramming and its effect on aging. So happy to be working in this field. New exciting tools and resources coming soon! 🚀
1
2
34
@aocampox
Alejandro Ocampo
7 months
Very happy to visit @bettslacroix and the team at @RetroBio_ today. Amazing to see in person what they are building and how fast they are moving! Fantastic company culture and energy. Thank you for having me!
@bettslacroix
Joe Betts-LaCroix
7 months
with @aocampox who kicked off this whole field of partial epigenetic reprogramming
Tweet media one
3
1
67
0
1
29
@aocampox
Alejandro Ocampo
6 months
Agree 100%. Very disappointing to see most "longevity" companies pivoting to obesity and disease, not even age-associated diseases anymore. We all know you need an indication, business model, investors, FDA, but this is clearly not the type of trials we all signed up to see!
@KarlPfleger
Karl Pfleger
6 months
Obesity is the hot topic in biotech/pharma right now. Alas, I fear this may be a bad thing for the aging field, something that sidetracks the field. I'm prob one of the few not to fully celebrate BioAge's recent huge series D round. I'm good friends with the company & happy for
17
5
77
6
2
28
@aocampox
Alejandro Ocampo
9 months
This is terrible news. @DogAgingProject is one of the most important projects in the field. A unique way to learn more about aging and help human’s best friend. An inspiration for companies like @epiterna_ and @loyalfordogs Please follow @mkaeberlein requests and save DAP!🐶❤️
@mkaeberlein
Matt Kaeberlein
9 months
Help save the Dog Aging Project. Despite being one of the most influential, productive and impactful NIH supported projects over the past 5 years, the National Institute on Aging has inexplicably chosen to withdraw support for the Dog Aging Project. For now, I’m won't get into
62
305
597
0
7
27
@aocampox
Alejandro Ocampo
9 months
Twitter help! In line with my previous tweet, what private companies do you know that are testing drugs to evaluate their effect on the lifespan of animals? Testing might include large screenings, lifespan assays, work as CRO, preclinical studies, clinical trials. Please retweet!
5
14
25
@aocampox
Alejandro Ocampo
9 months
Great work by @kgiperez and @ParrasAlbert in collaboration with @prof_horvath where we analyze the epigenetic age of multiple mouse models of premature aging. Important results for the field showing DNA damage as potential driver of accelerated epigenetic age (threat):
@OcampoLab
Ocampo Lab
9 months
Latest paper from the lab where we analyze epigenetic age in multiple mouse models of premature aging. Importantly, our data reinforces the link between DNA damage and epigenetic dysregulation. Congratulations to all the authors!!
0
11
65
2
5
19
@aocampox
Alejandro Ocampo
8 months
The capacity of cellular reprogramming to rejuvenate cells continues to impress me. Latest manuscript from the @OcampoLab !!
@OcampoLab
Ocampo Lab
8 months
Happy to share our latest manuscript describing rejuvenation of cells from the mouse model of premature aging ERCC1 by partial reprogramming, even in the absence of proper DNA repair. Thank you to @trickpaine , members of the Ocampo Lab, and collaborators!
3
9
46
3
1
20
@aocampox
Alejandro Ocampo
10 months
New work from the @OcampoLab and members of @epiterna_ exploring the “dark side” of in vivo reprogramming. Just trying to better understand what happens when we reprogram living animals. Congratulations to everyone involved who are helping push the field forward!
@OcampoLab
Ocampo Lab
10 months
Very excited to share the latest paper from our laboratory where we investigated the adverse effects of in vivo reprogramming. We hope that our work can help this very promising field to move forward. Congratulations to the authors and collaborators!
7
41
184
1
6
20
@aocampox
Alejandro Ocampo
9 months
What private companies test drugs for lifespan extension? Quick summary: @IchorNews @epiterna_ @OraBiomedical @loyalfordogs @jacksonlab @LONGEVICA_LE @CromaticHQ @MagnitudeBio @Nagibioscience Do you know others companies? Please retweet! Thank you
4
5
18
@aocampox
Alejandro Ocampo
6 months
First report of @epiterna_ on the search for drugs that can extend human lifespan by analysis of data on more than 400 prescribed medication. Drugs that can extend human lifespan exist and we aim to discover more of them. Amazing work by Jonas Morin @kgiperez and collaborators!
@kgiperez
Kevin Perez
6 months
Happy to share the first manuscript coming out of @epiterna_ ! In this work we examine the association between more than 400 commonly prescribed medications and all-cause mortality risk in half a million participants of the UK Biobank.
6
24
102
1
6
21
@aocampox
Alejandro Ocampo
8 months
Support the Continuation of the Dog Aging Project (DAP)! 10k signatures collected and only 2.8k signatures more to reach @mkaeberlein goal! Please retweet, share,and sign!
Tweet media one
0
10
17
@aocampox
Alejandro Ocampo
7 months
To be successful in science, you need to be talented, smart, hard worker, and lucky. Many people think that one or two of these qualities are enough. I am very sorry but unfortunately they are wrong!
0
2
19
@aocampox
Alejandro Ocampo
8 months
One of my dreams and goals is for @epiterna_ to be to the ITP (Interventions Testing Program) what @SpaceX is to @nasa ! 🚀
1
0
14
@aocampox
Alejandro Ocampo
8 months
When will we see something like this in longevity where each rocket is the discovery of a lifespan extending intervention? We hope that companies like @epiterna_ will help us get there soon! 🚀
@MattDursh
Matt Dursh
8 months
wait till the end
143
918
5K
1
2
16
@aocampox
Alejandro Ocampo
8 months
The regulatory path is more open than what we think! Let’s stop procrastinating this type of trials blaming regulators, time and/or cost and let’s go for it! 🚀
@kgiperez
Kevin Perez
8 months
Think we’ve never done a lifespan trial in humans. We have, it was called the ASPREE (ASPirin in Reducing Events in the Elderly) study. ASPREE was a randomised, blinded, placebo-controlled clinical trial of low-dose (100mg) aspirin in healthy older
Tweet media one
6
15
58
0
2
15
@aocampox
Alejandro Ocampo
9 months
In my opinion, most clinical trials for the treatment of age-associated diseases by targeting fundamental mechanisms of aging will unfortunately fail! Although aging is the major risk factor for these diseases, it will be very difficult to treat them rather than prevent them!
1
5
15
@aocampox
Alejandro Ocampo
8 months
This decade is going to be lots of fun! Let’s keep building and pushing the limits of human lifespan!
@MaxUnfried
Max Unfried
8 months
This is the current real #longevity olympics. 10 oldest people alive right now! Let's see if @bryan_johnson is on that list in the next 65-70 years. Or anyone from the Longevity Community who should have longevity alpha.
Tweet media one
23
19
74
0
0
10
@aocampox
Alejandro Ocampo
7 months
💯
@mitchellblee33
Mitchell B Lee, PhD
7 months
If you don't understand how non-mammalian systems can be used to advance healthy longevity intervention discovery, then you haven't done the homework. Plain and simple.
5
1
21
0
0
12
@aocampox
Alejandro Ocampo
6 months
Very surprised nobody has started yet an in vivo reprogramming company to target obesity based on the significant decrease in body weight observed by intestinal de-differentiation! Maybe on stealth mode 🤫😂
2
1
10
@aocampox
Alejandro Ocampo
9 months
New review from the @OcampoLab about partial cellular reprogramming out today! Congratulations to @trickpaine and @adanguyenx for this fantastic collaboration!
@OcampoLab
Ocampo Lab
9 months
Great review by @trickpaine and @adanguyenx on partial cellular reprogramming. A novel rejuvenation technology with a great history!
0
19
68
0
0
12
@aocampox
Alejandro Ocampo
10 months
So grateful to be able to work everyday with some of the best minds on pushing the field forward! Thank you! 🚀
@OcampoLab
Ocampo Lab
10 months
Happy to announce the publication of our novel aging clock based on the analysis of chromatin accessibility by ATAC-seq! Amazing work of current and past members of @OcampoLab , collaborators, and members of the team at @epiterna_
1
13
87
1
0
11
@aocampox
Alejandro Ocampo
11 months
Learning is a skill and there is so much to learn. Master and enjoy learning, and you will be unstoppable!!
0
4
9
@aocampox
Alejandro Ocampo
9 months
An image is worth a thousand words! Drug discovery of lifespan extending interventions at large scale. Lifespan data generated at @epiterna_
Tweet media one
2
2
9
@aocampox
Alejandro Ocampo
6 months
Now we are talking! Ready to fly! 🚀
Tweet media one
0
0
8
@aocampox
Alejandro Ocampo
11 months
History on the making! @PLD_Space from Spain just put a Miura1 rocket in space! Congratulations to all the amazing Team and let’s keep pushing! 🇪🇸🇪🇺🚀
Tweet media one
0
1
6
@aocampox
Alejandro Ocampo
9 months
When founders and investors think about the market size of drugs that target the biology of aging, we all need to undergo a complete change of mindset!
@age1vc
age1
9 months
We found that a drug approved and indicated for aging would conservatively have a peak global market size ~$150-$200 billion annually. A company that owned only this drug would be more valuable than the top 2 big pharma companies (J&J and Pfizer) in terms of revenue…combined.
Tweet media one
36
65
314
0
1
7
@aocampox
Alejandro Ocampo
9 months
Congratulations to @celinehalioua and the team at @loyalfordogs for this great achievement! Thank you so much for their great work that is helping the field move forward.
@loyalfordogs
Loyal
9 months
We announced a major milestone with the FDA today. Watch below to learn what this means for large-breed dogs everywhere.
4
17
103
0
0
7
@aocampox
Alejandro Ocampo
11 months
Amazing to see the change in perception when you start seen everything (active or passive, positive or negative) that happens to you as a learning experience. Just learn from everyone and everything. Thanks to all the people that have helped me and/or keep helping me to learn!
0
2
6
@aocampox
Alejandro Ocampo
11 months
Great interview by my Co-Founder @kgiperez on the work and vision of @epiterna_ ! Amazing years ahead and really looking forward to sharing the journey with this great Team! 🚀
@kgiperez
Kevin Perez
11 months
My interview with @BiopoleLausanne on "How repurposing drugs for healthy ageing could lengthen lifespans", describing some of the outstanding work we are doing @epiterna_ !
0
4
7
2
2
5
@aocampox
Alejandro Ocampo
1 year
Thank you Andrew! Lots of fun and a great pleasure to chat with you about reprogramming for your fantastic book!
@statto
Andrew Steele
1 year
Congrats to @stanete who I spoke to earlier this year about moving into the longevity startup world, who is joining the brilliant @aocampox (who I had a lot of fun chatting to about reprogramming for Ageless) at @epiterna_ :
1
3
18
0
0
5
@aocampox
Alejandro Ocampo
8 months
So much learning in this thread!
@KRHornberger
Keith Hornberger
8 months
There’s a frequent perception among recent entrants to drug discovery world that if we could just find drug candidates faster, this will be a useful accelerant to the overall process. The issue is: this thinking is mostly (but not entirely) incorrect. 🧵 1/
Tweet media one
23
118
683
1
0
5
@aocampox
Alejandro Ocampo
7 months
“The best way to predict the future is to invent it” - Mark Zuckerberg 💯🚀
1
0
4
@aocampox
Alejandro Ocampo
7 months
💯
@HarryStebbings
Harry Stebbings
7 months
Pre-seed investing is very simple: We invest in generational defining founders with outlier mindsets who are in directionally interesting markets. The question is can you find them and win them over anyone else? That is where true alpha lies.
46
32
435
0
0
4
@aocampox
Alejandro Ocampo
1 year
On days like today, this is gold! 🙌🏻
@eldsjal
Daniel Ek
1 year
I have my guiding motto on a wall in my house. It’s a quote from George Bernard Shaw that says: “The reasonable man adapts himself to the world; the unreasonable one persists in trying to adapt the world to himself. Therefore, all progress depends on the unreasonable man.” I am
174
538
4K
0
0
4
@aocampox
Alejandro Ocampo
9 months
Agree 100% with @kgiperez co-founder of @epiterna_ We (as a field) have made very small progress during the last decade. In order to discover more and better drugs, we need to test more drugs!
@kgiperez
Kevin Perez
9 months
A good way to assess if we are making progress in the field is to look at the best lifespan extension achieved so far in the ITP. So far, the best result for a single drug (excluding combinations) is for Rapamycin, in female mice, at 42ppm (+28%).
Tweet media one
6
11
63
0
0
4
@aocampox
Alejandro Ocampo
10 months
If life was to cost $1 per day, a 100 year life would cost $36’500. Is the cost too low or life too short?
1
1
4
@aocampox
Alejandro Ocampo
8 months
Amazing person and scientist. Her work will have an impact in the field forever. Very sad moments. All the best for her family and friends.
@kapahi_pankaj
Pankaj kapahi
8 months
I'm deeply saddened to share that we have lost a remarkable friend, a wonderful mentor and esteemed colleague, Judith Campisi. Judith's impact on those around her was profound and lasting. Her legacy will continue to inspire us all. Rest in peace, Judy. You will be greatly missed
Tweet media one
73
109
409
0
0
4
@aocampox
Alejandro Ocampo
8 months
Thank you everyone for your likes, replies, and private messages. I really appreciate them. All the best for 2024!
0
0
3
@aocampox
Alejandro Ocampo
9 months
The one and only!! So grateful to have Richard as part of our Advisory Board at @epiterna_
@age1vc
age1
9 months
Richard Miller is a renowned figure in our field. We're delighted to soon share a new series focused on the latest developments in longevity biotech. We'll kick off with a special feature on the Interventions Testing Program, including insights from Dr. Miller himself.
Tweet media one
1
2
25
0
0
4
@aocampox
Alejandro Ocampo
9 months
Today I spent time with @kgiperez to discuss the work of @epiterna_ during 2023. It was amazing to see so much progress and new drugs that can extend lifespan. Looking forward to sharing more data in our blog soon!
0
0
3
@aocampox
Alejandro Ocampo
9 months
Exciting news! @kgiperez co-founder and Head of Research at @epiterna_   describing the first steps of our journey to discovery novel drugs that can extend healthy lifespan in pets and people!
0
1
3
@aocampox
Alejandro Ocampo
9 months
@Aging_Scientist @ArtemyShumskiy Great idea! This is exactly the work we are doing at @epiterna_ Primary HTS in yeast, worms, and flies, followed by secondary screenings in killifish and mice. Tens of novel drugs that extend lifespan already discovered at the first stage. More info coming soon!
1
2
3
@aocampox
Alejandro Ocampo
8 months
💯🚀
@HarryStebbings
Harry Stebbings
8 months
Embrace being underestimated, it is one of the biggest advantages you can have. You have to be willing to work for years in the dark with little to no credit. By the time the world sees what you have built, it needs to be too late for them to stop you.
11
41
237
0
0
3
@aocampox
Alejandro Ocampo
9 months
Great article about one of the best companies in the field @RetroBio_ !
@ashleevance
Ashlee Vance
9 months
A couple of years ago, @sama aimed $180 million at Retro in a bid to see if humans could extend their lives by 10 healthy, vigorous years. Here's an exclusive look at what the company has been up to.
7
23
249
0
1
3
@aocampox
Alejandro Ocampo
9 months
@stanete @epiterna_ @kgiperez It was fantastic to work with @stanete over the last few months. So motivated, hardworker, and passionate about the field. Best of luck for whatever you do next!
0
0
2
@aocampox
Alejandro Ocampo
9 months
Second blog post about the progress of @epiterna_ In less than 18 months, we have tested 315 drugs. 91 (29%) show a positive effect in at least one organism. 45 are “absolutely novel” and were not known to extend lifespan before. So much biology of aging to be discovered!! 🚀
@kgiperez
Kevin Perez
9 months
Today we release the second post of our blog @epiterna_ , where we try to give you a glimpse at the magnitude of what we've built here! You will find there some update on our progress, preliminary data about popular anti-aging drugs, as well as some of our most promising
Tweet media one
1
2
4
0
0
2
@aocampox
Alejandro Ocampo
9 months
Thank you for the invitation @4ever_healthy Looking forward to participate in this fantastic meeting!
@4ever_healthy
Forever Healthy
9 months
We are happy to announce Alejandro Ocampo ( @OcampoLab ), Co-Founder and CEO of Epiterna, and Professor at the University de Lausanne, as a speaker for the #RejuvenationStartupSummit2024 . Alejandro has made fundamental contributions to the epigenetic reprogramming field, as
Tweet media one
0
4
12
0
0
2
@aocampox
Alejandro Ocampo
9 months
@ZaneKoch6 Great question! We will publish a new paper on this topic in the upcoming days. Cellular reprogramming can improve DNA damage even in cells from Ercc1 mice
0
0
2
@aocampox
Alejandro Ocampo
8 months
@KarlPfleger @IchorNews @epiterna_ @OraBiomedical @loyalfordogs @jacksonlab @LONGEVICA_LE @CromaticHQ @MagnitudeBio @Nagibioscience @realNathanCheng @jpsenescence @spannr_ @venture_radar Thank you for your reply Karl. I really appreciate your feedback and comments. Indeed your company database represents one of the most extensive lists in the field, although as you said it is difficult to find out what companies are testing drugs for lifespan extension.
1
0
0
@aocampox
Alejandro Ocampo
11 months
Great to follow the progress of companies in the field! Let’s keep building!
@loyalfordogs
Loyal
11 months
Vets and vet techs have burning questions to ask, and our Director of Clinical Development has burning answers to offer. Read our most frequently asked questions from vets on our aging theses and products. →
0
2
3
0
0
2
@aocampox
Alejandro Ocampo
6 months
@CharlesMBrenner Thank you for the correction. Agree that prospective randomized clinical trials will be needed in order to make those conclusions.
1
0
1
@aocampox
Alejandro Ocampo
8 months
@samuelgil Day One!! Always Day One!!
0
0
2
@aocampox
Alejandro Ocampo
7 months
💯
@BUILD_OR_DIE
BUILD OR DIE
7 months
Sam Altman ( @sama ): "The most underrated quality is being really determined. This is more important than being smart, having a network or a great idea. So much about being a successful entrepreneur is just not giving up."
76
455
3K
0
0
2
@aocampox
Alejandro Ocampo
6 months
While there is association in mice between drugs than extend lifespan and loss of body weight (BW), there are examples of extension without BW loss, and BW loss without extension. What if loss of BW is a requirement for extension, but not necessarily the MOA? @AlexanderMWolf7
1
0
2
@aocampox
Alejandro Ocampo
8 months
@epiterna_ develops affordable and clinically proven drugs capable of safely extending healthy lifespan for pets and people.
0
1
2
@aocampox
Alejandro Ocampo
6 months
🚀🙈
@kgiperez
Kevin Perez
6 months
😮
Tweet media one
5
1
21
0
0
2
@aocampox
Alejandro Ocampo
9 months
@celinehalioua Bravo Celine! Congratulations!
0
0
1
@aocampox
Alejandro Ocampo
6 months
@CharlesMBrenner Looking forward to future similar association studies on NAD+ precursor and delay all-caused mortality when enough data is available.
1
0
1
@aocampox
Alejandro Ocampo
11 months
This is gold! Thank you @samuelgil Learning to train the mind as well!
@samuelgil
Samuel Gil
11 months
Tweet media one
4
8
60
1
1
1
@aocampox
Alejandro Ocampo
9 months
@DrMorganLevine @CharlesMBrenner Thank you for the clarification and kind words. Really appreciate it. Agree, lots of misinformation out there.
0
0
0
@aocampox
Alejandro Ocampo
6 months
@CharlesMBrenner I think that we are entering into a discussion about semantics. I agree that medicine extends lifespan of patients. In addition, if a drug can extend the lifespan of patient beyond the lifespan of healthy controls, this drug could potentially extend human lifespan.
0
0
0
@aocampox
Alejandro Ocampo
9 months
@JMarcVX @OcampoLab @epiterna_ Totally agreed. Hopefully pets (dogs and cats) and humans coming soon. That is our goal!
0
0
1
@aocampox
Alejandro Ocampo
8 months
@PeLuzZIo_ @epiterna_ I expect/hope the approval of the first lifespan extending drug for companion dogs in 2026 and for humans by 2030
0
0
0
@aocampox
Alejandro Ocampo
8 months
@AdamsBioAging Thank you for your kind words Peter. Happy to help increasing our basic understanding about reprogramming.
0
0
1
@aocampox
Alejandro Ocampo
8 months
@DocLarus Same for you Shahaf! Definitely not continuously, maybe in cycles or avoiding certain organs 😀
0
0
1
@aocampox
Alejandro Ocampo
9 months
@MichaelShadpour @OcampoLab @epiterna_ Great question! In this figure, different treatment for each organism. More data coming soon on conserved lifespan extending drugs working in multiple organisms!
0
0
1
@aocampox
Alejandro Ocampo
11 months
So true! Know the feeling!
@HarryStebbings
Harry Stebbings
11 months
Running marathons is like company building:. 1. Periods of jubilance & periods of true pain. 2. Don't view it in its entirety. It's too daunting. Break it down to small parts. 3. Run your own race. You only compete w/ yourself. Always take the next step. Do not give up.
13
7
77
0
0
1